AIM ImmunoTech, Inc. (AIM)
0.2297
0.00 (0.00%)
USD |
NYAM |
Sep 08, 16:00
0.2297
0.00 (0.00%)
Pre-Market: 09:09
AIM ImmunoTech Total Assets (Quarterly) : 12.73M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.73M |
| March 31, 2026 | 8.585M |
| December 31, 2025 | 5.782M |
| September 30, 2025 | 5.494M |
| June 30, 2025 | 4.129M |
| March 31, 2025 | 6.248M |
| December 31, 2024 | 51.49M |
| September 30, 2024 | 13.59M |
| June 30, 2024 | 15.72M |
| March 31, 2024 | 16.19M |
| December 31, 2023 | 19.42M |
| September 30, 2023 | 27.86M |
| June 30, 2023 | 33.62M |
| March 31, 2023 | 37.46M |
| December 31, 2022 | 69.92M |
| September 30, 2022 | 46.28M |
| June 30, 2022 | 50.88M |
| March 31, 2022 | 54.16M |
| December 31, 2021 | 81.41M |
| September 30, 2021 | 63.08M |
| June 30, 2021 | 66.72M |
| March 31, 2021 | 74.09M |
| December 31, 2020 | 111.02M |
| September 30, 2020 | 64.16M |
| June 30, 2020 | 50.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 42.41M |
| December 31, 2019 | 65.31M |
| September 30, 2019 | 22.49M |
| June 30, 2019 | 13.81M |
| March 31, 2019 | 15.96M |
| December 31, 2018 | 54.13M |
| September 30, 2018 | 15.17M |
| June 30, 2018 | 15.68M |
| March 31, 2018 | 16.26M |
| December 31, 2017 | 14.21M |
| September 30, 2017 | 14.72M |
| June 30, 2017 | 16.11M |
| March 31, 2017 | 16.86M |
| December 31, 2016 | 18.87M |
| September 30, 2016 | 21.58M |
| June 30, 2016 | 21.92M |
| March 31, 2016 | 21.50M |
| December 31, 2015 | 22.80M |
| September 30, 2015 | 26.50M |
| June 30, 2015 | 29.87M |
| March 31, 2015 | 30.79M |
| December 31, 2014 | 29.44M |
| September 30, 2014 | 30.64M |
| June 30, 2014 | 33.55M |
| March 31, 2014 | 35.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.987M |
| Shareholders Equity (Quarterly) | 7.744M |
| Debt to Equity Ratio | 0.5063 |
| Current Ratio | 2.109 |
| Net Debt Paydown Yield | -3.40% |